Tecentriq is used to treat adults with non-small cell lung cancer (NSCLC), extensive-stage small cell lung cancer (SCLC), hepatocellular carcinoma, melanoma, or muscle-invasive bladder cancer (MIBC), and for patients aged 2 and older with alveolar soft part sarcoma (ASPS).